NextBillion - An Initiative of the William Davidson Institute at the University of Michigan

Wednesday, October 14, 2015

A Chinese firm plans to mass produce a military-developed vaccine against Ebola, even as the epidemic which killed more than 11,000 people in West Africa beings to fade.

Privately held Tianjin CanSino Biotechnology Inc is investing 2 billion yuan ($315.14 million) to build a facility in the northeastern city of Tianjin where it will produce the vaccine, an official at the firm told Reuters on Wednesday.

Official news agency Xinhua had earlier reported the news.

The facility will be completed by around 2017-2018, but no date has yet been set for production to start, the official added. The vaccine has been developed by a team at the China's Academy of Military Medical Sciences.